Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Copley AL , Robb TP Studies on platelets. III. The effect of heparin in vivo on the platelet count in mice and dogs. Am J Clin Pathol 1942; 12:563.

Fidlar E. , Jacques LB The effect of commercial heparin on the platelet count. J Lab Clin Med 1948;33:1410.

Chong BH Heparin-induced thrombocytopenia. Br J Haematol 1995;89:431.

King DJ , Kelton JG Heparin-associated thrombocytopenia. Ann Intern Med 1984;100:535.

Laster JL , Nichols WK , Silver D. Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies. Arch Intern Med 1989;149:2285.

Rama BN , Haake RE , Bander SJ , et al. Heparin-flush associated thrombocytopenia-induced hemorrhage: a case report. Nebr Med J 1991 ;76:392.

Visentin GP , Ford SE , Scott JP , Aster RH Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81.

Kelton JG , Warkentin TE Heparin-induced thrombocytopenia: what the serologists have taught us. J Lab Clin Med 1996;128:346.

Amiral J. , Wolf M. , Fischer AM , et al. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996;92:954.

10.

Cines DB , Tomaski A. , Tannenbaum S. Immune endothelial-cell injury in heparin associated thrombocytopenia . N Engl J Med 1987;316:581.

11.

Warkentin TE , Hayward Cpm , Bochkov LK , et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with pro-coagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994;84:3691.

12.

Katopodis JN , Kolodny L. , Jy W. , et al. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997;54:95.

13.

Amiral J. , Marfaing-Koka A. , Wolf M. , et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996;88:410.

14.

Gardyn J. , Sorkin P. , Kluger Y. , et al. Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance. Am J Hematol 1995;50:292.

15.

Gruel Y. , Rupin A. , Watier H. , et al. Anticardiolipin antibodies in heparin-associated thrombocytopenia . Thromb Res 1992;67:601.

16.

Weismann RE , Tobin RW Arterial embolism occurring during systemic heparin therapy. Arch Surg 1958;76:219.

17.

Dryjski M. , Dryjski H. Heparin induced thrombocytopenia. Eur J Vasc Endovasc Surg 1996;11:260.

18.

Schmitt BP , Adelman B. Heparin-associated thrombocytopenia: a critical review and a pooled analysis . Am J Med Sci 1993;305:208.

19.

Warkentin TE , Levine MN , Hirsh J. , et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin . N Engl J Med 1995 ;332:1330.

20.

Warkentin TE , Kelton JG A 14 year study of heparin-induced thrombocytopenia . Am J Med 1996;101:502.

21.

Boshkov LK , Warkentin TE , Hayward Cpm , et al. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993;84:322.

22.

Nand S. , Wong W. , Yuen B. , et al. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997;56:12.

23.

Warkentin TE , Elavathil LJ , Hayward Cpm , et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997;127:804.

24.

Raskob GE , George JN Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med 1997 ;127:839.

25.

Hach-Wunderle V. , Kainer I. , Krug B. , et al. Heparin-associated thrombosis despite normal platelet counts. Lancet 1994;344:469.

26.

Baughman RP , Lower EE , Flessa HC , Tollerud DJ Thrombocytopenia in the intensive care unit . Chest 1993;104:1243.

27.

Bauer TL , Arepally G. , Konkle BA , et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997;95:1242.

28.

Chong BH , Burgess J. , Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993;69:344.

29.

Kelton JG , Warkentin TE Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination. Am J Clin Pathol 1995;104:611.

30.

Arepally GT , Reynolds C. , Tomaski A. , et al. Comparison of PF4/ heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia . Am J Clin Pathol 1995;104:648.

31.

Look KA , Sahud M. , Flaherty S. , Zehnder JL Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis . Am J Clin Pathol 1997;108:78.

32.

Isenhart CE , Brandt JT Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1993;99:324.

33.

Suh JS , Malik MI , Aster RH , Visentin GP Characterization of the humoral immune response in heparin-induced thrombocytopenia . Am J Hematol 1997;54:196.

34.

Aster RH Heparin-induced thrombocytopenia: understanding improves but questions remain . J Lab Clin Med 1996;127:418.

35.

Makhoul RG , McCann RL , Austin EH , et al. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. Ann Thorac Surg 1987;43:617.

36.

Sobel M. , Adelman B. , Szentpetery S. , et al. Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism. J Vasc Surg 1988;8:395.

37.

Nand S. , Robinson JA Plasmaphoresis in the management of heparin-associated thrombocytopenia with thrombosis. Am J Hematol 1988;28:204.

38.

Demers C. , Ginsberg JS , Brill-Edwards P. , et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia . Blood 1991 ;78:2194.

39.

Magnani HN Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (ORG 10172). Thromb Haemost 1993 ;70:554.

40.

Kitka MJ , Keller MP , Humphrey PW , Silver D. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 1993;114: 705.

41.

Lewis BE , Walenga JM , Wallis DE Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombosis syndrome. Semin Thromb Hemost 1997;23:197.

State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome

Abstract

Get full access to this article

References